[Update to the position paper of the Italian Society of Interventional Cardiology (SICI-GISE) on institutional and operator requirements for transcatheter aortic valve implantation (TAVI). Chapter 2: Technical nursing care in TAVI].

Update del documento di posizione della Società Italiana di Cardiologia Interventistica (SICI-GISE) sui requisiti minimi per ospedali ed operatori che eseguono procedure di impianto transcatetere di protesi valvolare aortica (TAVI). Capitolo 2: La realtà tecnico-infermieristica nella TAVI.

Journal

Giornale italiano di cardiologia (2006)
ISSN: 1972-6481
Titre abrégé: G Ital Cardiol (Rome)
Pays: Italy
ID NLM: 101263411

Informations de publication

Date de publication:
04 2020
Historique:
entrez: 7 4 2020
pubmed: 7 4 2020
medline: 28 4 2021
Statut: ppublish

Résumé

Calcific degenerative aortic stenosis is the most frequent valve disease in the western population. Transcatheter aortic valve implantation procedures are significantly increasing, as they now represent the first choice in inoperable patients and have been shown to be non-inferior to cardiac surgery in patients at high and intermediate surgical risk. In this scenario, it is necessary to define and standardize the technical nursing care to guarantee patient safety and improve quality of care.The purpose of this document is to propose, on the basis on currently available literature, a model for the development of assistance based on shared objectives and clinical competence.

Identifiants

pubmed: 32250372
doi: 10.1714/3336.33076
doi:

Types de publication

Journal Article Practice Guideline

Langues

ita

Sous-ensembles de citation

IM

Pagination

60S-69S

Auteurs

Matteo Longoni (M)

U.O. Emodinamica e Cardiologia Interventistica, Dipartimento Cardio-Toraco-Vascolare, IRCCS Ospedale San Raffaele, Milano.

Matteo Chiarabelli (M)

U.O. Cardiologia, Dipartimento Cardio-Toraco-Vascolare, Azienda Ospedaliero-Universitaria di Bologna, Policlinico S. Orsola-Malpighi, Bologna.

Francesco Germinal (F)

U.O. Emodinamica, Dipartimento Cardio-Toraco Vascolare, A.O. Vito Fazzi, Lecce.

Fabio Negrello (F)

U.O. Cardiologia, Dipartimento Cardio-Toraco-Vascolare, Azienda Ospedaliero-Universitaria di Bologna, Policlinico S. Orsola-Malpighi, Bologna.

Matteo Migliorini (M)

U.O. Radiologia Diagnostica ed Interventistica, Azienda Ospedaliera Universitaria di Ferrara, Arcispedale Sant'Anna, Cona (FE).

Sandra Griggio (S)

U.O. Emodinamica e Cardiologia Invasiva, Dipartimento di Scienze Cardiache, Toraciche e Vascolari, Policlinico Universitario, Padova.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH